Atropine Titration and Oxime Timing in Occupational Chlorpyrifos Poisoning
A 24-year-old farm worker is brought to a rural emergency department 4 hours after spraying chlorpyrifos without protective equipment. He has pinpoint pupils of 2 mm, profuse salivation, bronchorrhea, bradycardia of 48 beats/min, fasciculations in the calves, confusion, and vomiting. Oxygen saturation is 88% on room air. Red blood cell acetylcholinesterase activity is 28% of the laboratory baseline. The ECG shows a corrected QT interval of 460 ms. Atropine 2 mg IV is given and repeated, but secretions persist. Pralidoxime is not available for another 6 hours because of supply delays. The nearest intensive care bed is 90 minutes away. The team asks how to titrate atropine, whether delayed pralidoxime is still useful, and what complication to anticipate over the next 24 to 96 hours.
1. How should atropine be titrated, and which endpoints should guide dosing?
Read the worked answer
Atropine should be titrated to the patient's cholinergic signs, not to pupil size. The key endpoints are drying of pulmonary secretions and bronchorrhea, improved oxygenation and ventilation, heart rate above approximately 80 beats/min, and reduced salivation and sweating. Because this patient has bronchorrhea and hypoxemia, airway management and suctioning are immediate priorities. Atropine can be given as 1 to 2 mg IV boluses, doubling the dose every 3 to 5 minutes if secretions persist, because partial blockade requires escalating doses. Large cumulative doses may be needed in severe organophosphate poisoning. Pupil dilation is unreliable and can be confounded by hypoxia or prior drugs. The QT of 460 ms is a caution but not a reason to withhold life-saving atropine. Continuous cardiac monitoring, pulse oximetry, and frequent chest auscultation are essential. Once secretions clear and ventilation improves, the infusion or intermittent dosing can be tapered to avoid rebound.
2. Is pralidoxime still useful at 6 hours, and what is the anticipated intermediate syndrome?
Read the worked answer
Pralidoxime is still useful when given before aging of the enzyme-phosphate complex. For chlorpyrifos, aging is relatively slow compared with some other organophosphates, so administration at 6 hours can still reactivate a meaningful fraction of acetylcholinesterase, especially if the patient remains symptomatic. It should be given as soon as available, with repeated dosing or infusion according to protocol, while atropine continues. The anticipated complication is intermediate syndrome, typically developing 24 to 96 hours after exposure: proximal muscle weakness, neck flexion weakness, respiratory muscle weakness, and risk of aspiration or respiratory failure. Fasciculations may subside before weakness appears. The patient needs prolonged monitoring, serial respiratory assessment, and readiness for intubation. A delayed presentation does not exclude intermediate syndrome, and discharge after initial stabilization would be unsafe.
3. Why should succinylcholine be avoided if intubation is required?
Read the worked answer
Succinylcholine is metabolized by plasma butyrylcholinesterase, which is also inhibited in organophosphate poisoning. Its duration of neuromuscular blockade can therefore be markedly prolonged, and the patient may remain paralyzed after a standard dose. In a patient with already compromised respiratory function, this creates a dangerous inability to ventilate and assess neurologic status. A non-depolarizing neuromuscular blocker with a shorter predictable duration, or an appropriate alternative strategy, is preferred if intubation is needed. The broader point is that drug handling is altered by the poisoning itself, so standard emergency doses cannot be assumed to behave normally.